Cite

HARVARD Citation

    Foschi, M. et al. (2019). Evaluating dalfampridine for the treatment of relapsing-remitting multiple sclerosis: does it add to the treatment armamentarium?. Expert opinion on pharmacotherapy. pp. 1309-1320. [Online]. 
  
Back to record